<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0"><channel><title>Individual feed for https://www.2minutemedicine.com/feed/</title><link>https://www.2minutemedicine.com/feed/</link><description>Individual feed output.</description><lastBuildDate>Thu, 25 Dec 2025 11:01:56 GMT</lastBuildDate><generator>PyRSS2Gen-1.1.0</generator><docs>http://blogs.law.harvard.edu/tech/rss</docs><item><title>Prognostic value of premaintenance FDG PET/CT response in patients with newly diagnosed myeloma from the CASSIOPEIA trial</title><link>https://www.2minutemedicine.com/prognostic-value-of-premaintenance-fdg-pet-ct-response-in-patients-with-newly-diagnosed-myeloma-from-the-cassiopeia-trial/</link><image_url>https://www.2minutemedicine.com/wp-content/uploads/2018/01/myeloma-300x150.jpg</image_url><description>1. Premaintenance positron emission tomography (PET)/computed tomography (CT) and bone marrow multiparameter flow cytometry (BM MFC) are associated wi...</description><pubDate>Thu, 25 Dec 2025 00:00:17 GMT</pubDate></item><item><title>Contemporary medical therapy for heart failure across the ejection fraction spectrum: The OPTIPHARM-HF registry</title><link>https://www.2minutemedicine.com/contemporary-medical-therapy-for-heart-failure-across-the-ejection-fraction-spectrum-the-optipharm-hf-registry/</link><image_url>https://www.2minutemedicine.com/wp-content/uploads/2016/02/heart-failure-cardiomyopathy-300x150.jpg</image_url><description>1. Use of guideline-directed medical therapy (GDMT) in heart failure with reduced ejection fraction (HFrEF) and heart failure with mildly reduced ejec...</description><pubDate>Wed, 24 Dec 2025 00:00:13 GMT</pubDate></item><item><title>Tofacitinib for the Treatment of Juvenile Idiopathic Arthritis: Patient-Reported Outcomes in a Phase 3, Randomized, Double-Blind, Placebo-Controlled Withdrawal Trial</title><link>https://www.2minutemedicine.com/tofacitinib-for-the-treatment-of-juvenile-idiopathic-arthritis-patient-reported-outcomes-in-a-phase-3-randomized-double-blind-placebo-controlled-withdrawal-trial/</link><image_url>https://www.2minutemedicine.com/wp-content/uploads/2018/11/kidsplaying2_PD_edited-300x150.jpg</image_url><description>1. Tofacitinib significantly improves patient-reported outcomes compared to placebo in the management of juvenile idiopathic arthritis (JIA). Evidence...</description><pubDate>Tue, 23 Dec 2025 00:00:55 GMT</pubDate></item><item><title>Weekly islatravir plus lenacapavir maintains HIV virologic suppression</title><link>https://www.2minutemedicine.com/weekly-islatravir-plus-lenacapavir-maintains-hiv-virologic-suppression/</link><image_url>https://www.2minutemedicine.com/wp-content/uploads/2016/01/HIV1_CC_wiki_JRobertoTrujilo_edited-300x150.png</image_url><description>1. In this randomized controlled trial, once-weekly oral islatravir (ISL) plus lenacapavir (LEN) maintained high rates of HIV-1 virologic suppression ...</description><pubDate>Mon, 22 Dec 2025 23:00:49 GMT</pubDate></item><item><title>Certain cannabis-based products may offer modest reductions in pain</title><link>https://www.2minutemedicine.com/certain-cannabis-based-products-may-offer-modest-reductions-in-pain/</link><image_url>https://www.2minutemedicine.com/wp-content/uploads/2019/02/pills2_PD_edited-300x150.jpg</image_url><description>1. In this updated systematic review, cannabis-based products with a comparable or high tetrahydrocannabinol (THC)-to-cannabidiol (CBD) ratio may prov...</description><pubDate>Mon, 22 Dec 2025 22:00:45 GMT</pubDate></item></channel></rss>